Evaluation of probiotics effects on bilirubin level
- Conditions
- neonatal hyperbilirubinemia.P59.9 Neonatal jaundice, unspecified Physiological jaundice (intense)(prolonged) NOS
- Registration Number
- IRCT2017061018974N3
- Lead Sponsor
- Deputy Minister for Research and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
term infants with age between 3-10 days and gestational age of 42-37 weeks , birth weight equals or more than 2500 g , and bilirubin 12.9-up mg / dL at the start of phototherapy, and fed only by breast milk.Exclusion criteria: infants with blood disorders family, having signs of hemolysis due to blood group incompatibility, internal bleeding indoors due to complications of traumatic birth (exp : cephalohematom), suspected neonatal infection such as chorioamnionitis, intrauterine infection, sepsis and urinary tract infection, perinatal hypoxic newborns, having thyroid dysfunction, distress or respiratory failure, malfunction regulate body temperature and metabolic, hemodynamic instability and congenital heart disease, a history of maternal use of phenobarbital during the last month of pregnancy venous hematocrit 65%
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bilirubin level. Timepoint: from 1 to 4 days. Method of measurement: serum lilirubin level.
- Secondary Outcome Measures
Name Time Method Defecations times. Timepoint: 1 and 4 days. Method of measurement: mother report.